Yanhua Ding

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 16

Top Topics

Hepatitis B Virus

Top Venues

Antimicrobial agents and chemotherapy

Journal of clinical pharmacology

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Jing Zhou, Hong Zhang, Hong Chen, George Zhang, John Mao, Tianxiang Zhang, Yanan Tang, Wenhao Yan, Chuanjing Li, Yanhua Ding, Qinglong Jin
Pharmacokinetics and safety of GST-HG171, a novel 3CL protease inhibitor, in Chinese subjects with impaired and normal liver function. Antimicrobial agents and chemotherapy 68 (8) (2024)
Jing Zhou, Hong Zhang, Hong Chen, George Zhang, John Mao, Tianxiang Zhang, Yanan Tang, Wenhao Yan, Chuanjing Li, Yanhua Ding, Qinglong Jin
Pharmacokinetics and safety of GST-HG171, a novel 3CL protease inhibitor, in Chinese subjects with impaired and normal liver function. Antimicrobial agents and chemotherapy 68 (8) (2024)
Jing Zhou, Hong Zhang, Hong Chen, George Zhang, John Mao, Tianxiang Zhang, Yanan Tang, Wenhao Yan, Chuanjing Li, Yanhua Ding, Qinglong Jin
Pharmacokinetics and safety of GST-HG171, a novel 3CL protease inhibitor, in Chinese subjects with impaired and normal liver function. Antimicrobial agents and chemotherapy 68 (8) (2024)
Jing Zhou, Hong Zhang, Hong Chen, George Zhang, John Mao, Tianxiang Zhang, Yanan Tang, Wenhao Yan, Chuanjing Li, Yanhua Ding, Qinglong Jin
Pharmacokinetics and safety of GST-HG171, a novel 3CL protease inhibitor, in Chinese subjects with impaired and normal liver function. Antimicrobial agents and chemotherapy 68 (8) (2024)
Cuiyun Li, Haijun Li, Jiajia Mai, Hong Zhang, Min Wu, Yanhua Ding, Jufang Huang
Single-Dose Tolerability and Pharmacokinetics of Onradivir in Chinese Patients with Hepatic Impairment and Healthy Matched Controls. Journal of clinical pharmacology (2024)
Jing Zhou, Hong Zhang, Hong Chen, George Zhang, John Mao, Tianxiang Zhang, Yanan Tang, Wenhao Yan, Chuanjing Li, Yanhua Ding, Qinglong Jin
Pharmacokinetics and safety of GST-HG171, a novel 3CL protease inhibitor, in Chinese subjects with impaired and normal liver function. Antimicrobial agents and chemotherapy (2024)
Hong Zhang, Jing Zhou, Hong Chen, John Mao, Yanan Tang, Wenhao Yan, Tianxiang Zhang, Chuanjing Li, Shikui Chen, Guoping Li, George Zhang, Yanhua Ding, Li Liu
Phase I study, and dosing regimen selection for a pivotal COVID-19 trial of GST-HG171. Antimicrobial agents and chemotherapy 68 (1) (2023)
Hong Zhang, Jing Zhou, Hong Chen, John Mao, Yanan Tang, Wenhao Yan, Tianxiang Zhang, Chuanjing Li, Shikui Chen, Guoping Li, George Zhang, Yanhua Ding, Li Liu
Phase I study, and dosing regimen selection for a pivotal COVID-19 trial of GST-HG171. Antimicrobial agents and chemotherapy 68 (1) (2023)
Hong Zhang, Jing Zhou, Hong Chen, John Mao, Yanan Tang, Wenhao Yan, Tianxiang Zhang, Chuanjing Li, Shikui Chen, Guoping Li, George Zhang, Yanhua Ding, Li Liu
Phase I study, and dosing regimen selection for a pivotal COVID-19 trial of GST-HG171. Antimicrobial agents and chemotherapy 68 (1) (2023)
Hong Zhang, Jing Zhou, Hong Chen, John Mao, Yanan Tang, Wenhao Yan, Tianxiang Zhang, Chuanjing Li, Shikui Chen, Guoping Li, George Zhang, Yanhua Ding, Li Liu
Phase I study, and dosing regimen selection for a pivotal COVID-19 trial of GST-HG171. Antimicrobial agents and chemotherapy 68 (1) (2023)
Hong Zhang, Jing Zhou, Hong Chen, John Mao, Yanan Tang, Wenhao Yan, Tianxiang Zhang, Chuanjing Li, Shikui Chen, Guoping Li, George Zhang, Yanhua Ding, Li Liu
Phase I study, and dosing regimen selection for a pivotal COVID-19 trial of GST-HG171. Antimicrobial agents and chemotherapy (2023)
Yue Hu, Haijun Li, Hong Zhang, Xiaoxin Chen, Jinjun Chen, Zhongyuan Xu, Hong You, Ruihua Dong, Yun Peng, Jing Li, Xiaojiao Li, Dandan Wu, Lei Zhang, Di Cao, He Jin, Dongdong Qiu, Aruhan Yang, Jinfeng Lou, Xiaoxue Zhu, Junqi Niu, Yanhua Ding
ZSP1601, a novel pan-phosphodiesterase inhibitor for the treatment of NAFLD, A randomized, placebo-controlled phase Ib/IIa trial. Nature communications 14 (1) (2023)
Hong Zhang, Jing Zhou, Hong Chen, John Mao, Yanan Tang, Wenhao Yan, Tianxiang Zhang, Chuanjing Li, Shikui Chen, Guoping Li, George Zhang, Yanhua Ding, Li Liu
Phase I study, and dosing regimen selection for a pivotal COVID-19 trial of GST-HG171. Antimicrobial agents and chemotherapy 68 (1) (2023)
Hong Zhang, Jing Zhou, Hong Chen, John Mao, Yanan Tang, Wenhao Yan, Tianxiang Zhang, Chuanjing Li, Shikui Chen, Guoping Li, George Zhang, Yanhua Ding, Li Liu
Phase I study, and dosing regimen selection for a pivotal COVID-19 trial of GST-HG171. Antimicrobial agents and chemotherapy 68 (1) (2023)
Xiaojiao Li, Yusi Liu, Hanxin Yao, Meng Wang, Lei Gao, Jinfeng Lou, John Mao, Wenqiang Wu, Yixin Zhou, Yanan Tang, Wenhao Yan, Yanbin Hu, Charles Ding, Shuhui Chen, Junqi Niu, Yanhua Ding
Safety, Tolerability, and Pharmacokinetics of the Novel Hepatitis B Virus Expression Inhibitor GST-HG131 in Healthy Chinese Subjects: a First-in-Human Single- and Multiple-Dose Escalation Trial. Antimicrobial agents and chemotherapy 66 (5) (2022)
Cuiyun Li, Min Wu, Hong Zhang, Jiajia Mai, Lizhi Yang, Yanhua Ding, Junqi Niu, John Mao, Wenqiang Wu, Dong Zhang, Yanan Tang, Wenhao Yan
Safety, Tolerability, and Pharmacokinetics of the Novel Hepatitis B Virus Capsid Assembly Modulator GST-HG141 in Healthy Chinese Subjects: a First-in-Human Single- and Multiple-Dose Escalation Trial. Antimicrobial agents and chemotherapy 65 (10) (2021)